Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-31 @ 8:34 PM
Study NCT ID:
NCT04599634
Status:
COMPLETED
Last Update Posted:
2025-02-04
First Post:
2020-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-22
First Submit QC Date:
None
Study First Post Date:
2020-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-17
Results First Submit QC Date:
None
Results First Post Date:
2025-02-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-13
Last Update Post Date:
2025-02-04
Last Update Post Date Type:
ACTUAL